172 related articles for article (PubMed ID: 18322390)
1. Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.
Dudas B; Rose M; Cornelli U; Pavlovich A; Hanin I
Neurodegener Dis; 2008; 5(3-4):200-5. PubMed ID: 18322390
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.
Rose M; Dudas B; Cornelli U; Hanin I
Neurobiol Aging; 2003; 24(3):481-90. PubMed ID: 12600723
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Dudas B; Rose M; Cornelli U; Hanin I
Brain Res; 2005 Feb; 1033(1):34-40. PubMed ID: 15680337
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Rose M; Dudas B; Cornelli U; Hanin I
Brain Res; 2004 Jul; 1015(1-2):96-102. PubMed ID: 15223371
[TBL] [Abstract][Full Text] [Related]
5. Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Dudas B; Cornelli U; Lee JM; Hejna MJ; Walzer M; Lorens SA; Mervis RF; Fareed J; Hanin I
Neurobiol Aging; 2002; 23(1):97-104. PubMed ID: 11755024
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans and neuroprotection.
Dudas B; Semeniken K
Handb Exp Pharmacol; 2012; (207):325-43. PubMed ID: 22566231
[TBL] [Abstract][Full Text] [Related]
8. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
Castillo GM; Lukito W; Wight TN; Snow AD
J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
[TBL] [Abstract][Full Text] [Related]
9. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
Ariga T; Miyatake T; Yu RK
J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
[TBL] [Abstract][Full Text] [Related]
10. Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease.
Wang P; Ding K
Protein Pept Lett; 2014; 21(10):1048-56. PubMed ID: 24975673
[TBL] [Abstract][Full Text] [Related]
11. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of soyabean isoflavone co-administration with folic acid against beta-amyloid 1-40-induced neurotoxicity in rats.
Ma WW; Xiang L; Yu HL; Yuan LH; Guo AM; Xiao YX; Li L; Xiao R
Br J Nutr; 2009 Aug; 102(4):502-5. PubMed ID: 19534845
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
Díaz-Nido J; Wandosell F; Avila J
Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective properties of resveratrol and derivatives.
Richard T; Pawlus AD; Iglésias ML; Pedrot E; Waffo-Teguo P; Mérillon JM; Monti JP
Ann N Y Acad Sci; 2011 Jan; 1215():103-8. PubMed ID: 21261647
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
17. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Dudas B; Hanin I; Rose M; Wülfert E
Neurobiol Dis; 2004 Mar; 15(2):262-8. PubMed ID: 15006696
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of cordycepin inhibit Aβ-induced apoptosis in hippocampal neurons.
Song H; Huang LP; Li Y; Liu C; Wang S; Meng W; Wei S; Liu XP; Gong Y; Yao LH
Neurotoxicology; 2018 Sep; 68():73-80. PubMed ID: 30031108
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humanin.
Park TY; Kim SH; Shin YC; Lee NH; Lee RK; Shim JH; Glimcher LH; Mook-Jung I; Cheong E; Kim WK; Honda F; Morio T; Lim JS; Lee SK
J Control Release; 2013 Mar; 166(3):307-15. PubMed ID: 23298615
[TBL] [Abstract][Full Text] [Related]
20. Purple rice berry is neuroprotective and enhances cognition in a rat model of Alzheimer's disease.
Pannangrong W; Wattanathorn J; Muchimapura S; Tiamkao S; Tong-Un T
J Med Food; 2011; 14(7-8):688-94. PubMed ID: 21510741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
